Horizon Therapeutics
HZNP
#927
Rank
NZ$45.31 B
Marketcap
NZ$197.90
Share price
0.00%
Change (1 day)
7.04%
Change (1 year)

EPS for Horizon Therapeutics (HZNP)

EPS in 2023 (TTM): NZ$3.18

According to Horizon Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ$3.27. In 2022 the company made an earnings per share (EPS) of NZ$3.88 a decrease over its 2021 EPS that were of NZ$4.00.

EPS history for Horizon Therapeutics from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ$3.18-18.09%
2022NZ$3.88-2.98%
2021NZ$4.0034.29%
2020NZ$2.98-42.43%
2019NZ$5.17-1021.21%
2018NZ-$0.56-86.9%
2017NZ-$4.29142.31%
2016NZ-$1.77-572.73%
2015NZ$0.37-105.96%
2014NZ-$6.2857.69%
2013NZ-$3.98-7.51%
2012NZ-$4.31-86.04%
2011NZ-$30.830.09%
2010NZ-$30.8059.23%
2009NZ-$19.35

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.31-29.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.38 646.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.44 280.75%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$10.09 208.85%๐Ÿ‡ฌ๐Ÿ‡ง UK
Dr. Reddy's Laboratories
RDY
NZ$1.32-59.45%๐Ÿ‡ฎ๐Ÿ‡ณ India